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Abstract
Background: The WHO Framework Convention on Tobacco Control was shown to effectively lower smoking
prevalence in in high income countries, however knowledge for low and middle income settings is sparse. The
objective of this study was to describe WHO MPOWER policy measures in thirteen West-African countries and to
investigate their correlation with smoking prevalence.
Methods: Age-standardized smoking prevalence data and policy measures were collected from various WHO reports.
For analysis MPOWER measures from 2008 and 2010, were combined with prevalence data from 2009 and 2011.
Multiple linear regression models were set up.
Results: In West-Africa mean smoking prevalence was approximately 20 % among males and approximately
3 % among females. Policy measures were mostly at a middle or low level. Regression analysis showed that
tobacco cessation programs, health warnings on cigarettes, and higher price of cigarettes were negatively
correlated with smoking prevalence. Significant effects were observed for only one policy measure (tobacco
cessation programs) and only within the male population where smoking prevalence is generally higher.
Conclusions: Tobacco control policies are enforced at relatively low levels in West-African countries. However,
improving tobacco control policy implementation according to the WHO Framework Convention on Tobacco
Control should assist in the reduction of smoking prevalence in African countries, thereby counteracting
pro-smoking initiatives set forth by the tobacco industry.
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Background
Diseases related to tobacco consumption rank among
the most preventable causes of deaths and disability
among adults in the world today [1]. The 2011 World
Health Organization (WHO) report on the Global
Tobacco Epidemic highlighted that tobacco use kills
nearly 6 million people and causes several hundred
billion dollars of economic damage worldwide each
year [2]. By the year 2025, the total number of
tobacco users is expected to increase further and
three times as many people are estimated to die from
smoking-related diseases. More than 80 % of these
premature deaths are predicted to occur in low and
middle income countries, where health facilities and
services are inadequately equipped to cope with the
demands presented by the tobacco epidemic [3].
Most African nations still remain in the early
stages of the tobacco epidemic, with an overall lower
smoking prevalences and lower smoking intensities
than observed in other parts of the world [4, 5].
However, it is important to note that smoking preva-
lence values vary significantly between individual
countries.
For example, Guinea with a smoking prevalence of
52 % in 2002 ranked among the top 10 countries
with the highest smoking prevalence worldwide,
whereas Ghana and Senegal both had significantly
lower reported smoking prevalences of <5 % [2, 6].
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Longitudinal data for Africa are sparse and few
reliable data on smoking prevalence are available in
the literature. Estimates on longitudinal trends of
tobacco smoking in Africa show a relatively low and
stable age-standardized prevalence of about 16 %
among males and 3 % among females [6]. However,
indicators of increasing activities from the tobacco
industry in African countries have been observed,
which may lead to a higher smoking prevalence in
the absence of proper tobacco control policy imple-
mentation [7].
In response to the globalization of tobacco epi-
demic, the WHO Framework Convention on Tobacco
Control (FCTC), was adopted by the World Health
Assembly in May 2003 and entered into force in
February 2005. In 2008, the WHO introduced the
MPOWER package in order to assist countries in the
fulfillment of WHO FCTC obligations. This policy
package is intended to scale up global tobacco
control, and covers six measures to assist in the
country-level implementation of effective interventions
to reduce the demand for tobacco: monitoring
tobacco use and prevention policies, implement
smoke free laws, offer help to quit tobacco use, warn
about tobacco dangers, advertisement bans, and raise
taxes on tobacco [8]. MPOWER measures reported by
the WHO allow for both standardized comparisons
between countries and within countries themselves
over a predefined period of time.
While it is known from studies in industrialized
countries that public health efforts can be successful
in reducing smoking prevalence, the effect of such
action has not yet been investigated in most West-
African countries [9]. In this ecological study, we will
use WHO’s MPOWER measures to describe tobacco
control policies in thirteen West-African countries,
and analyze their relation to country-wide smoking
prevalence data to strengthen successful tobacco
control policy in West-Africa.
Methods
Data sources
We used sex-specific age-standardized smoking preva-
lence estimates of thirteen West-African countries (Benin,
Burkina Faso, Cape Verde, Côte d’Ivoire, Gambia, Ghana,
Guinea, Mali, Mauritania, Niger, Nigeria, Senegal and
Sierra Leone) from WHO reports years 2009 and 2011
[2, 10]. The remaining three West-African countries
(Guinea-Bissau, Liberia and Togo) were excluded
from the study due to missing data. These WHO
estimates are based on different national or subna-
tional surveys, which were constructed for the pur-
pose of comparing adult tobacco use prevalence
across multiple time periods within the same country
[10]. Age-standardized smoking prevalence for Burkina
Faso in 2011 was derived from a global estimation study
on tobacco smoking [6]. Smoking prevalence was defined
as smoking at the time of the survey including daily and
non-daily use of any form of tobacco, such as ciga-
rettes, cigars, pipes, etc. excluding smokeless tobacco.
A detailed description of all underlying surveys is
given in the Appendix 1.
Information pertaining to smoking prevention policies
are based on reports to the Conference of the Parties
(COP) published by the WHO for the years 2008 and
2010 [2, 8]. The MPOWER measures smoke-free places,
tobacco treatment, health warning, advertisement ban,
and national agency were then categorized into four
groups according to the WHO standard as shown in
Table 1. Additionally, cigarette price in international dol-
lars adjusted for purchasing power was extracted from
the reports for all countries. All data used for the study
are freely available from the cited WHO documents.
Statistical methods
Multiple linear regression models were used to examine
the correlation of the different MPOWER measures on
smoking prevalence. Smoking prevalence percentage was
used as a continuous dependent variable and coded
MPOWER measures were set as independent variables.
Since percentages fall in a sufficiently narrow range it is
appropriate to model these directly with linear regres-
sion if the [11]. This is the case with our data (see
Discussion). The MPOWER measures from 2008 were
combined with prevalence estimates for 2009, and
similarly the measures from 2010 with prevalence
estimates from 2011. Therefore, all countries provided
two observations. Since the observations were not
independent, the inference was done by bootstrapping
the p-values, where the observations from one
country were taken as the bootstrap unit [12]. The
bootstrap sample size was taken as 1000. The full
dataset is given in the appendix. Due to very low
smoking prevalence among women, the analysis was done
for both sexes separately. For sensitivity analyses, we also
fit the models for the two years separately. Note that
with the available data we are not able to make any
statement on a causal relation between smoking
prevalence and these potentially influential factors.
Results
Extracted policy measures and smoking prevalence
data are presented in Table 2. The average smoking
prevalence among West-African males (unweighted
mean) was 20.9 %, while it was only 3.9 % among
females. There was no clear trend towards an increas-
ing prevalence between 2009 and 2011. When looking
at individual countries the decrease in male smoking
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prevalence was seen for Guinea (-2.1 %) and Côte d’Ivoire
(-1.3 %) whereas the strongest increase was seen for Sierra
Leone (+9.4 %) followed by Benin (+5.8 %) and Ghana
(+3.4 %). Among females smoking prevalence decreased
strongest for Burkina Faso (-4.0 %), but increased for
Sierra Leone (+11.8 %) followed by Côte d’Ivoire (+5.4 %)
and Ghana (+4.4 %).
The distribution of observed policy intervention is
shown in Table 1. Overall average levels of all interven-
tions were at a middle or low level (level 1 or 2). 60 % of
the price for a pack of 20 cigarettes was above 2.00
international dollars. Compared with policy interven-
tions in 2008, some smoking prevention policies have
been weakened in 2010, e.g. smoke-free places and
cessation services. Health warning remained at a low
level. Moreover, the cigarette price adjusted for purchas-
ing power decreased from 2.08 international dollars in
2008 to 2.04 international dollars in 2010.
Figure 1 demonstrates the negative correlation be-
tween cigarette price and the smoking prevalence
among males. No correlation was observed for females.
Similar conclusion can be drawn through the analysis
of other policy interventions and smoking prevalence,
e.g. smoke-free places, health warning, etc. (results
shown in Additional file 1).
The multiple linear regression analysis shown in
Table 3 show that all policy indicators are independ-
ently correlated with smoking prevalence. All indica-
tors resulted in negative coefficients. Since the dataset
was small, the bootstrapped p-values were mostly not
Table 1 Coding of MPOWER measures and their observed distribution in West-African countries
Variable Level Description Codea Observed distribution
2008 2010
Current smoking prevalence Prevalence of tobacco smoking [%]
Mean 11.7 % 13.1 %
Median 8.6 % 9.5 %
Range (<0.1–38.6 %) (<0.1–48.0 %)
Number of smoke-free places
(smoke-free places)
I ≤2 public places completely smoke-free 0 6 (47 %) 8 (61 %)
II 3–5 public places completely smoke-free 1 3 (23 %) 3 (23 %)
III 6–7 public places completely smoke-free 2 2 (15 %) 1 (8 %)
IV All public places completely smoke-free 3 2 (15 %) 1 (8 %)
Level of cessation service
(tobacco treatment)
I None 0 3 (23 %) 3 (23 %)
II Some cessation service not cost-covered 1 6 (47 %) 7 (54 %)
III At least one service is cost-covered 2 4 (30 %) 3 (23 %)
IV National quit line, services cost-covered 3 0 (0 %) 0 (0 %)
Level of health warning labels
(health warning)
I No warnings 0 9 (70 %) 10 (77 %)
II Medium size warnings with missing characteristics 1 4 (30 %) 3 (23 %)
III Medium size warnings 2 0 (0 %) 0 (0 %)
IV Large warnings 3 0 (0 %) 0 (0 %)
Level of bans on advertising, promotion
and sponsorship (advertisement ban)
I No ban 0 4 (30 %) 5 (38 %)
II Ban on TV, radio and print media 1 5 (39 %) 2 (15 %)
III Ban on TV, radio and print media, and on some
direct and/or indirect advertising
2 3 (23 %) 5 (39 %)
IV Ban on all forms of advertising 3 1 (8 %) 1 (8 %)
Level of tobacco control program
(national agency)
I No national agency on tobacco control 0 2 (15 %) 2 (15 %)
II Existence of national agency 1 5 (39 %) 3 (23 %)
III National agency with ≤5 staff members 2 2 (15 %) 4 (31 %)
IV National agency with >5 staff members 3 4 (31 %) 4 (31 %)
Price of cigarettes (adjusted price) Price of 20-cigarette pack in dollars (at purchasing
power parity)
[$]
Mean $2.08 $2.04
Median $2.3 $2.3
Range ($1.00–2.95) ($0.86–2.94)
aAs used in regression
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significant at the commonly used α = 0.05 level and
the estimates must be interpreted accordingly. The
model variables explained a large part of the variation
of smoking prevalence among males (R2 = 0.8). The
model for females revealed similar results, however,
due to the low prevalence of smoking in females, the
effects were lower and the estimates had higher p-values.
In order to analyze the impact of using several
observations per country we performed a sensitivity ana-
lysis by limiting the dataset to one observation per coun-
try. Results show that although the estimated coefficients
for the policy indicators change little, p-values increase
strongly due to the smaller number of observations.
Discussion
The study results gave an overview of recent smoking
prevalence data and tobacco control policies implemented
in West-African countries. Smoking prevalence was not
high, but the analysis of tobacco control policies revealed
that most countries have not yet achieved full FCTC
implementation. Furthermore, it was shown that policy
measurements suggested by the WHO correlated with
reduced smoking prevalence in Western Africa. Highest
impacts on prevalence were seen for tobacco cessation
programs, health warning and cigarette price.
A recent study on the relation of smoking preva-
lence and policy interventions measured in a com-
bined policy score also showed the reducing effect of
policy on smoking prevalence in 59 countries world-
wide [9]. However, this study only included three
West-African countries.
The availability and implementation of tobacco cessa-
tion programs as recommended in Article 14 of the
FCTC appear to be lowly prioritized, particularly in
lower-income countries [13]. Although nicotine replace-
ment therapies were proven to be effective at increasing
Table 2 Data on policy measures and smoking prevalence in West-African countries
Country Smoking prevalence Policy intervention
Year prevalence Males Females Year policy Smoke-free
places
Tobacco
treatment
Health
warning
Advertisement National
agency
Adjusted
price [$]
Benin 2009 15.2 % 1.5 % 2008 1 1 1 2 2 2.18
Benin 2011 21.0 % 3.0 % 2010 1 1 1 2 2 2.13
Burkina Faso 2009 18.2 % 8.0 % 2008 1 2 0 0 1 2.44
Burkina Faso 2011 20.0 % 4.0 % 2010 3 1 0 2 1 2.33
Cape Verde 2009 13.5 % 3.4 % 2008 0 2 0 1 1 2.95
Cape Verde 2011 14.0 % 3.0 % 2010 0 2 0 1 2 2.78
Côte d’Ivoire 2009 17.3 % 3.6 % 2008 0 1 1 1 3 2.28
Côte d’Ivoire 2011 16.0 % 9.0 % 2010 0 1 0 0 3 2.29
Gambia 2009 31.3 % 2.7 % 2008 2 0 0 2 1 1.31
Gambia 2011 32.0 % 3.0 % 2010 0 0 1 2 1 1.19
Ghana 2009 10.6 % 2.6 % 2008 0 1 1 1 2 2.94
Ghana 2011 14.0 % 7.0 % 2010 0 1 0 1 2 2.94
Guinea 2009 25.1 % 1.9 % 2008 3 1 0 2 3 1.00
Guinea 2011 23.0 % 2.0 % 2010 2 1 0 2 3 0.86
Mali 2009 28.5 % 2.2 % 2008 2 1 0 1 1 2.70
Mali 2011 28.0 % 2.0 % 2010 0 1 0 2 2 2.56
Mauritania 2009 29.4 % 4.1 % 2008 0 0 0 0 0 2.59
Mauritania 2011 29.0 % 4.0 % 2010 0 0 0 0 0 2.78
Niger 2009 8.9 % 0.0 % 2008 3 1 1 3 1 1.69
Niger 2011 9.0 % 0.4 % 2010 1 1 1 3 1 1.57
Nigeria 2009 10.5 % 2.6 % 2008 1 2 0 0 3 2.35
Nigeria 2011 10.0 % 2.0 % 2010 1 2 0 0 3 2.66
Senegal 2009 15.6 % 0.0 % 2008 0 2 0 1 3 1.48
Senegal 2011 16.0 % 0.4 % 2010 0 2 0 0 3 1.50
Sierra Leone 2009 38.6 % 8.2 % 2008 0 0 0 0 0 1.17
Sierra Leone 2011 48.0 % 20.0 % 2010 0 0 0 0 0 0.99
Winkler et al. BMC Public Health  (2015) 15:1216 Page 4 of 8
the success rate of smoking cessation and therefore at
lowering smoking prevalence, potential harm and benefits
of alternative nicotine delivery systems are still under in-
vestigation [14, 15].
Comprehensive tobacco advertising bans as recom-
mended in Article 13 of the FCTC were proven to be ef-
fective at both preventing tobacco initiation as well as
encouraging smokers to quit. Advertising bans seem
even more effective in low and middle income countries
than in high income countries [16].
Sufficient evidence has shown that the cigarette
price strongly correlates with smoking prevalence, and
that raising cigarette retail price (as recommended in
Article 6 of the FCTC) reduces cigarette consump-
tion significantly [2]. Other studies have suggested
that the relative contribution of cigarette price on
the reduction of male smoking prevalence is above
60 % [17, 18]. This heavy influence of cigarette price
on the reduction of smoking prevalence may function
in two different ways: current and future smokers may be
prevented from smoking altogether, and/or preexisting
smokers may reduce their overall cigarette intake [19, 20].
Although cigarette pricing is an important strategy of
tobacco control, the absolute value of cigarette price may
be misleading without considering affordability [21].
Compared with western-countries, the affordability of
Fig. 1 Correlation of cigarette price (adjusted for purchasing power) and smoking prevalence for the time periods 2008/2009 (top) and 2010/2011 (bottom)
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cigarettes in many West African nations has increased in
the past decades due to higher income obtained [21, 22].
As mentioned before, smoking patterns between
men and women in West Africa differ. Therefore,
effective smoking prevention policies require consider-
ation of gender differences. According to the esti-
mates from the regression model without taking into
account p-values, health warnings seem to have the
largest impact on female smokers, followed by adver-
tisement bans. In contrast, tobacco cessation pro-
grams seem to be the policy factor with the largest
impact on male smoking prevalence, followed by
health warning labels and cigarette price. Interestingly
the WHO has reported that women are increasingly
targeted by the tobacco industry in many countries
[10]. Therefore, it is important to ensure that particular
political smoking reduction strategies take into account
gender differences.
The data for our study are sparse. More information
on time trends both with respect to smioking prevalence
as well as prevention measures would have strengthened
our analysis. Therefore, we unfortunately could not
explore a dynamic relationship between policy imple-
mentation and smoking prevalence in this study. Some
countries have not established a functional surveillance
system to monitor tobacco use and tobacco control
measures.
As this study is an ecological study it exclusively
relies on aggregated data at the country level and
therefore suffers well known limitations related to
such analyses such as the ecological fallacy. Other
factors may exist which could partly explain differ-
ences in country-specific smoking prevalences. The
study is not large, and therefore the confidence inter-
vals are wide. The observed smoking prevalences,
with very few exceptions, fall within a relatively nar-
row range from 10 to 30 % in males and 0 to 20 %
in females. We therefore considered the linear regres-
sion approach an acceptable modeling system to use.
The use of more multiple observations per country is
taken into account by using a bootstrap approach to
estimate the confidence intervals. Results of the sensi-
tivity analysis showed there is only very limited im-
pact on the regression estimates by using several
observations per country. Due to the limited number
of observations we treated the categorical policy levels
of all policy interventions as continuous variables
within the multivariate regression model. This means
that the given estimates referred to the average
change per policy level or per one dollar in price.
However, in reality, the impact on smoking prevalence
may be different between for example policy level 1
to 2 and that of policy level 2 to 3. To take into
account such possible nonlinear relationships we per-
formed the multivariate linear regression by using
fractional polynomials, but this resulted in a standard
linear regression model. Overall, we are confident our
analyses are reasonable.
Policy measurements may also be biased by different
qualities of implementation. Furthermore, we cannot
rule out that extracted data is mixed with other political
factors, which are not directly measured but may influ-
ence the effects on the smoking prevalence.
Conclusion
Many West-African governments have implemented
some degree of tobacco control policy in response to
health and economic threats presented by increased
tobacco consumption. However, such tobacco control
policies require urgent strengthening in order to combat
recently enhanced activities of the tobacco industry in
West-African countries [23, 24]. Results of this study
support the hypothesis of smoking prevalence reduction
by the implementation of regulated tobacco control
policy, and hence may provide evidence necessary to
support future governmental decisions regarding the
strengthening of tobacco control policy.
Table 3 Coefficients of multiple linear regression model
Males Females
Independent variables β p-value* β p-value*
(Constant) 0.458 0.00 0.119 0.00
Smoke-free places −0.011 0.42 −0.003 0.57
Tobacco treatment −0.078 0.02 −0.011 0.56
Health warning on tobacco products −0.074 0.12 −0.042 0.42
Advertisement restricted/not allowed −0.009 0.60 −0.020 0.15
Tobacco Control program −0.018 0.30 −0.001 0.51
Price [$] (adj. purchasing power) −0.048 0.14 −0.013 0.72
Model R2 0.80 0.47
*Empirical bootstrap p-values
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Appendix 1
Additional file
Additional file 1: Correlation of policy interventions and smoking
prevalence for the time periods 2008/2009 (left) and 2010/2011
(right). (JPEG 3067 kb)
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